Human antiphospholipid antibodies induce TNFα in monocytes via Toll-like receptor 8

Immunobiology

Volumn 215, Issue 3, 2010, Pages 230-241

  Döring, Yvonne ^a   Hurst, Julia ^a   Lorenz, Mareike ^a   Prinz, Nadine ^a   Clemens, Natascha ^a   Drechsler, Maik D ^a   Bauer, Stefan ^b   Chapman, Joab ^c   Shoenfeld, Yehuda ^d   Blank, Miri ^d   Lackner, Karl J ^a   von Landenberg, Philipp ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c SHEBA MEDICAL CENTER   (Israel)

^d Center for Autoimmune Diseases   (Israel)

Author keywords

Antiphospholipid syndrome; Inate immunity; Monoclonal antibody; Monocytes; Toll like receptor 8

Indexed keywords

DNA ANTIBODY; IMMUNOGLOBULIN G; MESSENGER RNA; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; PHOSPHOLIPID ANTIBODY; TOLL LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR ALPHA;

ANTIBODY SPECIFICITY; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; INFLAMMATION; MALE; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; UPREGULATION;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIBODIES, MONOCLONAL; ANTIPHOSPHOLIPID SYNDROME; BLOTTING, WESTERN; CELL SEPARATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMANS; MONOCYTES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 8; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77949262403     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2009.03.002     Document Type: Article

References (48)

1. Asherson R.A. The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus 7 Suppl 2 2 (1998) S55-S62
2. Barrat F.J., Meeker T., Gregorio J., Chan J.H., Uematsu S., Akira S., et al. Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus. J. Exp. Med. 202 8 (2005) 1131-1139
3. Berman J., Girardi G., and Salmon J.E. TNF-alpha is a critical effector and a target for therapy in antiphospholipid antibody-induced pregnancy loss. J. Immunol. 174 1 (2005) 485-490
4. Beutler B. Inferences, questions and possibilities in Toll-like receptor signalling. Nature 430 6996 (2004) 257-263
5. Brown V., Brown R.A., Ozinsky A., Hesselberth J.R., and Fields S. Binding specificity of Toll-like receptor cytoplasmic domains. Eur. J. Immunol. 36 3 (2006) 742-753
6. Cekaite L., Furset G., Hovig E., and Sioud M. Gene expression analysis in blood cells in response to unmodified and 2′-modified siRNAs reveals TLR-dependent and independent effects. J. Mol. Biol. 365 1 (2007) 90-108
7. Cuadrado M.J., Lopez-Pedrera C., Khamashta M.A., Camps M.T., Tinahones F., Torres A., et al. Thrombosis in primary antiphospholipid syndrome: a pivotal role for monocyte tissue factor expression. Arthritis Rheum 40 (1997) 834-841
8. Deane J.A., Pisitkun P., Barrett R.S., Feigenbaum L., Town T., Ward J.M., et al. Control of toll-like receptor 7 expression is essential to restrict autoimmunity and dendritic cell proliferation. Immunity 27 5 (2007) 801-810
9. Dobado-Berrios P.M., Lopez-Pedrera C., Velasco F., Anguirre M.A., Torres A., and Cuadrado M.J. Increased levels of tissue factor mRNA in mononuclear blood cells of patients with primary antiphospholipid syndrome. Thromb. Haemostasis 82 (1999) 1578-1582
10. Dobado-Berrios P.M., Lopez-Pedrera C., Velasco F., and Cuadrado M.J. The role of tissue factor in the antiphospholipid syndrome [review]. Arthritis Rheum 44 (2001) 2467-2476
11. Espinola R.G., Liu X., Colden-Stanfield M., Hall J., Harris E.N., and Pierangeli S.S. E-Selectin mediates pathogenic effects of antiphospholipid antibodies. J. Thromb. Haemostasis 1 4 (2003) 843-848
12. Ferro D., Saliola M., Meroni P.L., Valesini G., Caroselli C., Pratico D., et al. Enhanced monocyte expression of tissue factor by oxidative stress in patients with antiphospholipid antibodies: effect of antioxidant treatment. J. Thromb. Haemostasis 1 3 (2003) 523-531
13. Fischer C., Buschmann K., Blank M., Stachl A., Miesbach W., Shoenfeld Y., et al. Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody. Immunobiology 211 9 (2006) 695-699
14. Forastiero R.R., Martinuzzo M.E., and de Larranaga G.F. Circulating levels of tissue factor and proinflammatory cytokines in patients with primary antiphospholipid syndrome or leprosy related antiphospholipid antibodies. Lupus 14 2 (2005) 129-136
15. Giannakopoulos B., Passam F., Rahgozar S., and Krilis S.A. Current concepts on the pathogenesis of the antiphospholipid syndrome. Blood 109 2 (2007) 422-430
16. Harris E.N., Englert H., Derve G., Hughes G.R., and Gharavi A. Antiphospholipid antibodies in acute Guillain-Barre syndrome. Lancet 2 8363 (1983) 1361-1362
17. Heil F., Ahmad-Nejad P., Hemmi H., Hochrein H., Ampenberger F., Gellert T., et al. The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33 11 (2003) 2987-2997
18. Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 5663 (2004) 1526-1529
19. Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 6813 (2000) 740-745
20. Jurk M., Heil F., Vollmer J., Schetter C., Krieg A.M., Wagner H., et al. Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 3 6 (2002) 499
21. Kornberg A., Blank M., Kaufman S., and Shoenfeld Y. Induction of tissue factor-like activity in monocytes by anti-cardiolipin antibodies. J. Immunol. 153 3 (1994) 1328-1332
22. Lackner K.J., von Landenberg C., Barlage S., and Schmitz G. Analysis of prothrombotic effects of two human monoclonal IgG antiphospholipid antibodies of apparently similar specificity. Thromb. Haemostasis 83 4 (2000) 583-588
23. Laemmli U. Cleavage of structural proteins during the assembly of the head of the bacteriophage T4. Nature 227 (1970) 680-685
24. Latz E., Schoenemeyer A., Visintin A., Fitzgerald K.A., Monks B.G., Knetter C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5 2 (2004) 190-198
25. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
26. Lopez-Pedrera C., Buendia P., Cuadrado M.J., Siendones E., Aguirre M.A., Barbarroja N., et al. Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway. Arthritis Rheum 54 1 (2006) 301-311
27. Marshak-Rothstein A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6 11 (2006) 823-835
28. Means T.K., Latz E., Hayashi F., Murali M.R., Golenbock D.T., and Luster A.D. Human lupus autoantibody-DNA complexes activate DCs through cooperation of CD32 and TLR9. J. Clin. Invest. 115 (2005) 407-417
29. Meroni P.L., Raschi E., Testoni C., Parisio A., and Borghi M.O. Innate immunity in the antiphospholipid syndrome: role of toll-like receptors in endothelial cell activation by antiphospholipid antibodies. Autoimmun. Rev. 3 7-8 (2004) 510-515
30. Meroni P.L., Raschi E., Testoni C., and Borghi M.O. Endothelial cell activation by antiphospholipid antibodies. Clin. Immunol. 112 (2004) 169-174
31. Nagase H., Okugawa S., Ota Y., Yamaguchi M., Tomizawa H., Matsushima K., et al. Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol. 171 8 (2003) 3977-3982
32. Nojima J., Masuda Y., Iwatani Y., Suehisa E., Futsukaichi Y., Kuratsune H., Watanabe Y., Takano T., Hidaka Y., and Kanakura Y. Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. Biochem. Biophys. Res. Commun. 365 4 (2008) 195-200
33. O'Neill L.A. How Toll-like receptors signal: what we know and what we don't know. Curr. Opin. Immunol. 18 1 (2006) 3-9
34. Øvstebø R., Haug K.B., Lande K., and Kierulf P. PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. Clin. Chem. 49 3 (2003) 425-432
35. Pierangeli S.S., Vega-Ostertag M.E., Raschi E., Liu X., Romay-Penabad Z., De Micheli V., et al. Toll like Receptor 4 is involved in antiphospholipid-mediated thrombosis: in vivo studies. Ann. Rheum. Dis. 29 (2007) 29
36. Raschi E., Testoni C., Bosisio D., Borghi M.O., Koike T., Mantovani A., et al. Role of the MyD88 transduction signaling pathway in endothelial activation by antiphospholipid antibodies. Blood 101 (2003) 3495-3500
37. Roubey R.A. Tissue factor pathway and the antiphospholipid syndrome. J. Autoimmun. 15 2 (2000) 217-220
38. Savarese E., Chae O.W., Trowitzsch S., Weber G., Kastner B., Akira S., et al. U1 small nuclear ribonucleoprotein immune complexes induce type I interferon in plasmacytoid dendritic cells through TLR7. Blood 107 8 (2006) 3229-3234
39. Shoenfeld Y. Etiology and pathogenetic mechanisms of the anti-phospholipid syndrome unraveled. Trends Immunol. 24 1 (2003) 2-4
40. Simitsopoulou M., Roilides E., Dotis J., Dalakiouridou M., Dudkova F., Andreadou E., et al. Differential expression of cytokines and chemokines in human monocytes induced by lipid formulations of amphotericin B. Antimicrob. Agents Chemother. 49 4 (2005) 1397-1403
41. Sorice M., Longo A., Capozzi A., Garofalo T., Misasi R., Alessandri C., Conti F., Buttari B., Riganò R., Ortona E., and Valesini G. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum 56 (2007) 2687-2697
42. Subramanian S., Tus K., Li Q.Z., Wang A., Tian X.H., Zhou J., et al. A Tlr7 translocation accelerates systemic autoimmunity in murine lupus. Proc. Natl. Acad. Sci. USA 103 26 (2006) 9970-9975
43. Uematsu S., and Akira S. Toll-like receptors and innate immunity. J. Mol. Med. 84 9 (2006) 712-725
44. Vega-Ostertag M., Casper K., Swerlick R., Ferrara D., Harris E.N., and Pierangeli S.S. Involvement of p38 MAPK in the up-regulation of tissue factor on endothelial cells by antiphospholipid antibodies. Arthritis Rheum 52 (2005) 1545-1554
45. Vollmer J., Tluk S., Schmitz C., Hamm S., Jurk M., Forsbach A., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. J. Exp. Med. 202 11 (2005) 1575-1585
46. von Landenberg C., Lackner K.J., von Landenberg P., Lang B., and Schmitz G. Isolation and characterization of two human monoclonal anti-phospholipid IgG from patients with autoimmune disease. J. Autoimmun. 13 2 (1999) 215-223
47. Wang J., Shao Y., Bennett T.A., Shankar R.A., Wightman P.D., and Reddy L.G. The functional effects of physical interactions among Toll-like receptors 7, 8, and 9. J. Biol. Chem. 281 49 (2006) 37427-37434
48. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 7 (1999) 1309-1311